Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02744027 · ClinicalTrials.gov registry record · NA

Imaging of Lymphatic Anomalies

A NA study, sponsored by Children's Hospital of Philadelphia.

Completed
Registry status
NA
Development phase
10
Enrollment target

NCT02744027: Completed NA study, sponsored by Children's Hospital of Philadelphia.

NCT02744027 is a NA study that has completed, run by Children's Hospital of Philadelphia. The registered enrollment target is 10 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02744027, a NA study, has completed, sponsored by Children's Hospital of Philadelphia.

COMPLETED
Registry status
NA
Development phase
10 participants
Enrollment target

Study Summary

Lymphatic Anomalies (LA) is characterized by proliferation of lymphatic tissue causing deterioration of pulmonary function. Understanding changes in lymphatic anatomy in these patients is hindered by the difficulty of imaging the lymphatic system. Dynamic Contrast Enhanced MR Lymphangiogram (DCMRL) may be useful in investigating pathological changes in the lymphatic system.

Primary Outcome

The primary endpoint will be the description of lymphatic anatomy assessing if participants have a single or branched Thoracic Duct.

Interventions

  • OTHER Dynamic Contrast Enhanced Magnetic Resonance Lymphangiography (DCMRL)
  • OTHER Heavy Weighted T2 Imaging (T2W)
  • OTHER Lymph Node Access

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2016-04
Est. Completion 2017-12
Phase NA
Children's Hospital of Philadelphia

431 total trials

What the finished NCT02744027 record still lists

NCT02744027 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 3 interventions - of which Dynamic Contrast Enhanced Magnetic Resonance Lymphangiography (DCMRL) is the first listed.

NCT02744027 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02744027 about?

NCT02744027 is a clinical study titled "Imaging of Lymphatic Anomalies". Lymphatic Anomalies (LA) is characterized by proliferation of lymphatic tissue causing deterioration of pulmonary function. Understanding changes in lymphatic anatomy in these patients is hindered by the difficulty of imaging the lymphatic system. Dynamic Contrast Enhanced MR Lymphangiogram (DCMRL) ...

What is the current status of trial NCT02744027?

This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2016-04. Estimated completion is 2017-12.

What interventions are being tested in trial NCT02744027?

The interventions under investigation include: Dynamic Contrast Enhanced Magnetic Resonance Lymphangiography (DCMRL) (OTHER), Heavy Weighted T2 Imaging (T2W) (OTHER), Lymph Node Access (OTHER).

Who is sponsoring clinical trial NCT02744027?

This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02744027's enrollment target sits among peer trials

10 1927th of 2000 higher than 26 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00623389 · 10 participants · NA

    Evaluation of an Advanced Lower Extremity Neuroprostheses

  • NCT01241864 · 10 participants · Phase 2

    Islet Transplantation in Type 1 Diabetic Kidney Allograft

  • NCT01293214 · 10 participants · NA

    Vascularized Composite Allotransplantation for Multiple Extremity Amputations

  • NCT01474148 · 10 participants · NA

    A Neuroprosthesis for Seated Posture and Balance

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02744027, the US trial registry maintained by the National Library of Medicine. NCT02744027 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.